Genomic Analysis of Residual TNBC After Neoadjuvant Therapy Deep Sequencing (Foundation Medicine) for 182 oncogenes in 72 evaluable cases with enough coverage JAK2 was novel and not seen in primary cases so far Balko JM, et al.
{}